Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UK, US, Australia To Begin New Cooperation On Hypersonic, Electronic Warfare Capabilities

-Reuters

byBenzinga Newsdesk

April 5, 2022

1 minute read

-Reuters

Here’s How Much You Would Have Made Owning T-Mobile US Stock In The Last 5 Years

By Benzinga Insights

Today, 7:37 AM

T-Mobile US (NASDAQ:TMUS) has outperformed the market over the past 5 years by 13.44% on an annualized basis producing an average annual return of 21.49%. Currently, T-Mobile US has a market capitalization of $185.74 billion.

TMUS

Morgan Stanley Maintains Equal-Weight on Hilton Worldwide Holdings, Raises Price Target to $144

By Benzinga Newsdesk

Today, 7:37 AM

Morgan Stanley maintains Hilton Worldwide Holdings (NYSE:HLT) with a Equal-Weight and raises the price target from $143 to $144.

HLT

Northwest Natural Holding Q3 EPS $(0.67) Beats $(0.75) Estimate, Sales $101.45M Beat $100.97M Estimate

By Benzinga Newsdesk

Today, 7:37 AM

Northwest Natural Holding (NYSE:NWN) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 9.84 percent decrease over losses of $(0.61) per share

NWN

FDA
News

EyePoint Pharmaceuticals Sponsored Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) Posted to Clinical Trials Website; Study is Not Yes Recruiting

By Charles Gross

Today, 7:37 AM

https://clinicaltrials.gov/ct2/show/NCT05381948

EYPT

UK, US, Australia To Begin New Cooperation On Hypersonic, Electronic Warfare Capabilities

Related Posts

Here’s How Much You Would Have Made Owning T-Mobile US Stock In The Last 5 Years

Morgan Stanley Maintains Equal-Weight on Hilton Worldwide Holdings, Raises Price Target to $144

Northwest Natural Holding Q3 EPS $(0.67) Beats $(0.75) Estimate, Sales $101.45M Beat $100.97M Estimate

EyePoint Pharmaceuticals Sponsored Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) Posted to Clinical Trials Website; Study is Not Yes Recruiting